SP420
CAS No. 911714-45-9
SP420( SP 420 | SP-420 )
Catalog No. M20105 CAS No. 911714-45-9
SP-420 is a novel orally active iron chelator.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 40 | In Stock |
|
5MG | 65 | In Stock |
|
10MG | 120 | In Stock |
|
25MG | 266 | In Stock |
|
50MG | 470 | In Stock |
|
100MG | 680 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSP420
-
NoteResearch use only, not for human use.
-
Brief DescriptionSP-420 is a novel orally active iron chelator.
-
DescriptionSP-420 is a novel orally active iron chelator.
-
In Vitro——
-
In Vivo——
-
SynonymsSP 420 | SP-420
-
PathwayOthers
-
TargetOther Targets
-
Recptoriron chelator
-
Research AreaOthers
-
IndicationIron overload
Chemical Information
-
CAS Number911714-45-9
-
Formula Weight355.41
-
Molecular FormulaC16H21NO6S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 35 mg/mL (98.48 mM)
-
SMILESCOCCOCCOc1ccc(C2=N[C@](C)(CS2)C(O)=O)c(O)c1
-
Chemical Name(4S)-45-Dihydro-2-[2-hydroxy-4-[2-(2-methoxyethoxy)ethoxy]phenyl]-4-methyl-4-thiazolecarboxylic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bergeron RJ et al. Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles. J Med Chem. 2012 Aug 23;55(16):7090-103.
molnova catalog
related products
-
Gimeracil
An inhibitor of dihydropyrimidine dehydrogenase, degrades pyrimidine including 5-fluorouracil in the blood.
-
Oxyphyllacinol
Oxyphyllacinol has antidiarrheal activity.Oxyphyllacinol has been shown to treat dementia. Oxyphyllacinol was isolated from the S. nodiflora water fraction, while the S. nodiflora water fraction has been shown to have antioxidant and anti-aging activities, inducing mitochondrial activity and increasing ctt1 gene expression by regulating stress tolerance response.
-
Gymnestrogenin
Gymnestrogenin has a dual LXRα±/α2 antagonistic profile.